Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
Abstract Relapses remain common among individuals with schizophrenia indicating a need for improved treatments. Creating a completely new drug molecule is expensive and time consuming, and therefore drug repurposing should be considered. Aim of this study was to investigate the risk of psychiatric r...
Guardado en:
Autores principales: | Jonne Lintunen, Markku Lähteenvuo, Jari Tiihonen, Antti Tanskanen, Heidi Taipale |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39076ad68fa7412396994fa04284c3ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Hannan Safiyyah Tan Sian Hui Abdullah, et al.
Publicado: (2021) -
Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
por: Noto H, et al.
Publicado: (2013) -
Personalizing the BioPsychoSocial Approach: “Add-Ons” and “Add-Ins” in Generalist Practice
por: William B. Ventres, et al.
Publicado: (2021) -
Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons
por: Rebecca Hagan, et al.
Publicado: (2021) -
Personalized medicine for schizophrenia
por: Peter F. Buckley, et al.
Publicado: (2017)